

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.94532122 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.94532122 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.82061793 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.82061793 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.34822629 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.83164147 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.83164147 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.83164147 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.74402557 |
| 10 | proteasome assembly (GO:0043248) | 5.74236452 |
| 11 | cysteine metabolic process (GO:0006534) | 5.58998250 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.52559176 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50730361 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.47497390 |
| 15 | lysine metabolic process (GO:0006553) | 5.24536038 |
| 16 | lysine catabolic process (GO:0006554) | 5.24536038 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.13299072 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.09079887 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.05484349 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.04535760 |
| 21 | urea cycle (GO:0000050) | 4.91180463 |
| 22 | urea metabolic process (GO:0019627) | 4.91180463 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.90202148 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.76853229 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.73566603 |
| 26 | urate metabolic process (GO:0046415) | 4.65506021 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.63327496 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.61691784 |
| 29 | drug catabolic process (GO:0042737) | 4.57405550 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.56749666 |
| 31 | protein maturation by protein folding (GO:0022417) | 4.54988360 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.53655770 |
| 33 | drug transmembrane transport (GO:0006855) | 4.51703146 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.43165348 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.42501188 |
| 36 | negative regulation of sterol transport (GO:0032372) | 4.42501188 |
| 37 | serine family amino acid metabolic process (GO:0009069) | 4.40430265 |
| 38 | bile acid metabolic process (GO:0008206) | 4.37167510 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.34642115 |
| 40 | glycine metabolic process (GO:0006544) | 4.34414976 |
| 41 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.33201830 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25963767 |
| 43 | protein carboxylation (GO:0018214) | 4.25963767 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 4.24312722 |
| 45 | regulation of fibrinolysis (GO:0051917) | 4.23576457 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.21113122 |
| 47 | serine family amino acid biosynthetic process (GO:0009070) | 4.20813281 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.19016425 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 4.16145187 |
| 50 | cellular amino acid catabolic process (GO:0009063) | 4.15673087 |
| 51 | complement activation, alternative pathway (GO:0006957) | 4.11312617 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.11183418 |
| 53 | exogenous drug catabolic process (GO:0042738) | 4.06537398 |
| 54 | ethanol oxidation (GO:0006069) | 4.05549202 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.05090524 |
| 56 | benzene-containing compound metabolic process (GO:0042537) | 4.04144762 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 4.03125705 |
| 58 | amine catabolic process (GO:0009310) | 4.02659965 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.02659965 |
| 60 | valine metabolic process (GO:0006573) | 4.02343459 |
| 61 | regulation of mitochondrial translation (GO:0070129) | 4.01702971 |
| 62 | regulation of protein activation cascade (GO:2000257) | 4.01052272 |
| 63 | aldehyde catabolic process (GO:0046185) | 4.00611546 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 3.99102103 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.99102103 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.99102103 |
| 67 | reverse cholesterol transport (GO:0043691) | 3.97506782 |
| 68 | phospholipid efflux (GO:0033700) | 3.96648904 |
| 69 | drug transport (GO:0015893) | 3.95195812 |
| 70 | cellular glucuronidation (GO:0052695) | 3.92011386 |
| 71 | acylglycerol homeostasis (GO:0055090) | 3.88092160 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.88092160 |
| 73 | chaperone-mediated protein transport (GO:0072321) | 3.87694554 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.85431540 |
| 75 | glutamate metabolic process (GO:0006536) | 3.82593481 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.78405597 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.78079116 |
| 78 | carboxylic acid catabolic process (GO:0046395) | 3.77941312 |
| 79 | organic acid catabolic process (GO:0016054) | 3.77941312 |
| 80 | carnitine metabolic process (GO:0009437) | 3.75934355 |
| 81 | protein complex biogenesis (GO:0070271) | 3.75597598 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 3.73844517 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.73011652 |
| 84 | regulation of complement activation (GO:0030449) | 3.72949193 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72386491 |
| 86 | drug metabolic process (GO:0017144) | 3.71326558 |
| 87 | fatty acid oxidation (GO:0019395) | 3.70989841 |
| 88 | bile acid and bile salt transport (GO:0015721) | 3.69101921 |
| 89 | ketone body metabolic process (GO:1902224) | 3.64480019 |
| 90 | lipid oxidation (GO:0034440) | 3.63902691 |
| 91 | coenzyme catabolic process (GO:0009109) | 3.61863823 |
| 92 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.60786100 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.60034823 |
| 94 | arginine metabolic process (GO:0006525) | 3.59567465 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.56929917 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.56929917 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.56205076 |
| 98 | respiratory electron transport chain (GO:0022904) | 3.55605216 |
| 99 | fatty acid catabolic process (GO:0009062) | 3.54640110 |
| 100 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.54062631 |
| 101 | respiratory chain complex IV assembly (GO:0008535) | 3.51253988 |
| 102 | ATP synthesis coupled proton transport (GO:0015986) | 3.48768741 |
| 103 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.48768741 |
| 104 | cellular response to zinc ion (GO:0071294) | 3.47562631 |
| 105 | branched-chain amino acid metabolic process (GO:0009081) | 3.47280945 |
| 106 | electron transport chain (GO:0022900) | 3.47132508 |
| 107 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.46562521 |
| 108 | plasma lipoprotein particle assembly (GO:0034377) | 3.43431434 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 3.43406681 |
| 110 | response to nitrosative stress (GO:0051409) | 3.40275946 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 3.38761475 |
| 112 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.38097751 |
| 113 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.38097751 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 3.37193348 |
| 115 | NAD biosynthetic process (GO:0009435) | 3.34813531 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.34314269 |
| 117 | cytochrome complex assembly (GO:0017004) | 3.27288175 |
| 118 | glutathione derivative metabolic process (GO:1901685) | 3.22515558 |
| 119 | glutathione derivative biosynthetic process (GO:1901687) | 3.22515558 |
| 120 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20574812 |
| 121 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.18490731 |
| 122 | negative regulation of ligase activity (GO:0051352) | 3.18490731 |
| 123 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17959078 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.10525423 |
| 125 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.04870993 |
| 126 | NADH dehydrogenase complex assembly (GO:0010257) | 3.04870993 |
| 127 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.04870993 |
| 128 | establishment of integrated proviral latency (GO:0075713) | 2.98515428 |
| 129 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.92933983 |
| 130 | termination of RNA polymerase III transcription (GO:0006386) | 2.92933983 |
| 131 | ventricular cardiac muscle cell development (GO:0055015) | 2.90957004 |
| 132 | cullin deneddylation (GO:0010388) | 2.90606987 |
| 133 | protein deneddylation (GO:0000338) | 2.88684435 |
| 134 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.87665037 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.82952640 |
| 136 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.75384629 |
| 137 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.75384629 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.71481186 |
| 139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.71481186 |
| 140 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.71481186 |
| 141 | establishment of viral latency (GO:0019043) | 2.70610117 |
| 142 | atrioventricular valve morphogenesis (GO:0003181) | 2.69588812 |
| 143 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.66853580 |
| 144 | kidney mesenchyme development (GO:0072074) | 2.65913721 |
| 145 | protein localization to kinetochore (GO:0034501) | 2.65653380 |
| 146 | regulation of metalloenzyme activity (GO:0048552) | 2.64704394 |
| 147 | skin morphogenesis (GO:0043589) | 2.63907874 |
| 148 | protein autoprocessing (GO:0016540) | 2.63853642 |
| 149 | transcription from mitochondrial promoter (GO:0006390) | 2.61058665 |
| 150 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.60885837 |
| 151 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.59842784 |
| 152 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.59842784 |
| 153 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.57056457 |
| 154 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.52332475 |
| 155 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.49057071 |
| 156 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48640231 |
| 157 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.48162804 |
| 158 | nucleoside salvage (GO:0043174) | 2.47140610 |
| 159 | positive regulation of ligase activity (GO:0051351) | 2.46628696 |
| 160 | protein targeting to mitochondrion (GO:0006626) | 2.44137510 |
| 161 | protein heterotetramerization (GO:0051290) | 2.41610003 |
| 162 | mitotic nuclear envelope reassembly (GO:0007084) | 2.41167002 |
| 163 | nuclear envelope reassembly (GO:0031468) | 2.41167002 |
| 164 | mannosylation (GO:0097502) | 2.39864440 |
| 165 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.39424949 |
| 166 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.38253746 |
| 167 | lactate metabolic process (GO:0006089) | 2.37296929 |
| 168 | metanephric mesenchyme development (GO:0072075) | 2.35040664 |
| 169 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.33398510 |
| 170 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.31270546 |
| 171 | rRNA modification (GO:0000154) | 2.28657957 |
| 172 | chondrocyte proliferation (GO:0035988) | 2.27864591 |
| 173 | regulation of ligase activity (GO:0051340) | 2.27186089 |
| 174 | GTP biosynthetic process (GO:0006183) | 2.26775239 |
| 175 | GDP-mannose metabolic process (GO:0019673) | 2.26612680 |
| 176 | cellular response to cadmium ion (GO:0071276) | 2.26534434 |
| 177 | protein localization to mitochondrion (GO:0070585) | 2.25640142 |
| 178 | rRNA methylation (GO:0031167) | 2.24533203 |
| 179 | extracellular negative regulation of signal transduction (GO:1900116) | 2.24320023 |
| 180 | extracellular regulation of signal transduction (GO:1900115) | 2.24320023 |
| 181 | regulation of cellular amine metabolic process (GO:0033238) | 2.24090657 |
| 182 | pattern specification involved in kidney development (GO:0061004) | 2.21553394 |
| 183 | heart contraction (GO:0060047) | 2.20644976 |
| 184 | heart process (GO:0003015) | 2.20644976 |
| 185 | tRNA methylation (GO:0030488) | 2.19590103 |
| 186 | response to redox state (GO:0051775) | 2.19360161 |
| 187 | negative regulation of receptor activity (GO:2000272) | 2.19160947 |
| 188 | establishment of protein localization to mitochondrion (GO:0072655) | 2.18870001 |
| 189 | negative regulation of protein ubiquitination (GO:0031397) | 2.18216775 |
| 190 | endothelial cell chemotaxis (GO:0035767) | 2.17284795 |
| 191 | ribosomal large subunit biogenesis (GO:0042273) | 2.17143849 |
| 192 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.16929294 |
| 193 | positive regulation of cell cycle arrest (GO:0071158) | 2.16878933 |
| 194 | endocardial cushion development (GO:0003197) | 2.16803853 |
| 195 | nucleoside transmembrane transport (GO:1901642) | 2.16676484 |
| 196 | positive regulation of actin filament depolymerization (GO:0030836) | 2.16110466 |
| 197 | ribosome assembly (GO:0042255) | 2.14970077 |
| 198 | DNA damage response, detection of DNA damage (GO:0042769) | 2.14961285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.10299721 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.27841201 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.83358896 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.26818110 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.20836997 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.57885054 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.42480043 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.18422575 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.83724508 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74792231 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.36268720 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.25806548 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.98313919 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.89016158 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.81415547 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.73157277 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.55294092 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.52210573 |
| 19 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.49499508 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.48650737 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.47405680 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.47358790 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.46815424 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.37743196 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33972993 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.32879489 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32654644 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10409539 |
| 29 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.00454074 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00334708 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0222953 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.88062358 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86184825 |
| 34 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.81718892 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.74241209 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73420503 |
| 37 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.70187532 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69263809 |
| 39 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.68131463 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67677644 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66771552 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60604152 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57686141 |
| 44 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.55812190 |
| 45 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.52349918 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.49827427 |
| 47 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46388122 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46379949 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45758595 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42998760 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36798838 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.36518239 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33160495 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32411641 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32343440 |
| 56 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.30796522 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24681364 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22770810 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22208808 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20026775 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19844730 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19167730 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18652705 |
| 64 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.18415281 |
| 65 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.17612903 |
| 66 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.17160240 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16921466 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16252070 |
| 69 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.13246165 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12063031 |
| 71 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10738645 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08748974 |
| 73 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08649827 |
| 74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07786683 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07424167 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06864149 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05580378 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03251877 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02408847 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02408847 |
| 81 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02298250 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01772601 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01503217 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01221824 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00930458 |
| 86 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.00638106 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99960515 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99521493 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99087750 |
| 90 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97077030 |
| 91 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96673086 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96433556 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95703840 |
| 94 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94804890 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94601884 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94351941 |
| 97 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93452520 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93205055 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92164369 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91537112 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90637356 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89971212 |
| 103 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89332537 |
| 104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89251889 |
| 105 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.88825444 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87813251 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87472235 |
| 108 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.87321292 |
| 109 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87185467 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86698837 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86296991 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85556955 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84729729 |
| 114 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84306992 |
| 115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.83824355 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83629076 |
| 117 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83034692 |
| 118 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81075086 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81050104 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80819122 |
| 121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80786981 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.80639928 |
| 123 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80006211 |
| 124 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.79634444 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.79503497 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.78812057 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78666276 |
| 128 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78551061 |
| 129 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78248382 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78157382 |
| 131 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.76975587 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76868766 |
| 133 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.76672251 |
| 134 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76196651 |
| 135 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.76163355 |
| 136 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.74187996 |
| 137 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74085554 |
| 138 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.73784906 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73725031 |
| 140 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73508504 |
| 141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73464808 |
| 142 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.73387361 |
| 143 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73331387 |
| 144 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73257455 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73162629 |
| 146 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72749712 |
| 147 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.72260851 |
| 148 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.71708936 |
| 149 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.71639356 |
| 150 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69871574 |
| 151 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69699307 |
| 152 | MYC_22102868_ChIP-Seq_BL_Human | 0.68991061 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.68935734 |
| 154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68225768 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68074258 |
| 156 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.67846532 |
| 157 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67135712 |
| 158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65107174 |
| 159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65005554 |
| 160 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64803811 |
| 161 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.64078951 |
| 162 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.63719642 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63605700 |
| 164 | MAF_26560356_Chip-Seq_TH1_Human | 0.63542714 |
| 165 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63302650 |
| 166 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62886030 |
| 167 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.62789589 |
| 168 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62708682 |
| 169 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.62402706 |
| 170 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.62383380 |
| 171 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62080330 |
| 172 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61817249 |
| 173 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61624320 |
| 174 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.61411033 |
| 175 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61344464 |
| 176 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60836383 |
| 177 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60280319 |
| 178 | P300_27268052_Chip-Seq_Bcells_Human | 0.60007254 |
| 179 | MYB_26560356_Chip-Seq_TH1_Human | 0.59398418 |
| 180 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.58455028 |
| 181 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57551966 |
| 182 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.57141077 |
| 183 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56930446 |
| 184 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.56683954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.39416975 |
| 2 | MP0005360_urolithiasis | 7.21249337 |
| 3 | MP0005365_abnormal_bile_salt | 5.50740354 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.42331727 |
| 5 | MP0010030_abnormal_orbit_morphology | 5.06584817 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.78907670 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.84479631 |
| 8 | MP0003252_abnormal_bile_duct | 3.41087838 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 3.36247523 |
| 10 | MP0005332_abnormal_amino_acid | 3.11906763 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.03425075 |
| 12 | MP0003941_abnormal_skin_development | 3.01001196 |
| 13 | MP0005503_abnormal_tendon_morphology | 2.85411830 |
| 14 | MP0004272_abnormal_basement_membrane | 2.72278288 |
| 15 | MP0009840_abnormal_foam_cell | 2.71302590 |
| 16 | MP0003195_calcinosis | 2.66511412 |
| 17 | MP0005083_abnormal_biliary_tract | 2.62429291 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.62144816 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.61388540 |
| 20 | MP0009384_cardiac_valve_regurgitation | 2.49586716 |
| 21 | MP0002295_abnormal_pulmonary_circulatio | 2.47314953 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.41791429 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.24296889 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.09267211 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.08053991 |
| 26 | MP0005275_abnormal_skin_tensile | 2.05853062 |
| 27 | MP0002938_white_spotting | 2.01136297 |
| 28 | MP0000609_abnormal_liver_physiology | 1.98834268 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.98621629 |
| 30 | MP0003279_aneurysm | 1.92696786 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.89197073 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.86649536 |
| 33 | MP0001764_abnormal_homeostasis | 1.85437495 |
| 34 | MP0003786_premature_aging | 1.85096281 |
| 35 | MP0003186_abnormal_redox_activity | 1.82241538 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68796607 |
| 37 | MP0000516_abnormal_urinary_system | 1.67574826 |
| 38 | MP0005367_renal/urinary_system_phenotyp | 1.67574826 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.66791278 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.59226605 |
| 41 | MP0003868_abnormal_feces_composition | 1.57274141 |
| 42 | MP0005508_abnormal_skeleton_morphology | 1.52005757 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.51100176 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.50065234 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.47782569 |
| 46 | MP0005451_abnormal_body_composition | 1.46931868 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.38778319 |
| 48 | MP0000049_abnormal_middle_ear | 1.36835932 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.34383138 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.33987092 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.29341500 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.27739884 |
| 53 | MP0005670_abnormal_white_adipose | 1.27153833 |
| 54 | MP0000598_abnormal_liver_morphology | 1.24728335 |
| 55 | MP0003283_abnormal_digestive_organ | 1.23660331 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.22723697 |
| 57 | MP0003718_maternal_effect | 1.22409406 |
| 58 | MP0009697_abnormal_copulation | 1.22226378 |
| 59 | MP0009764_decreased_sensitivity_to | 1.20973340 |
| 60 | MP0004133_heterotaxia | 1.19308466 |
| 61 | MP0008469_abnormal_protein_level | 1.17269162 |
| 62 | MP0001756_abnormal_urination | 1.16970534 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.16918825 |
| 64 | MP0005330_cardiomyopathy | 1.16642176 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 1.16376172 |
| 66 | MP0009053_abnormal_anal_canal | 1.15741675 |
| 67 | MP0003950_abnormal_plasma_membrane | 1.14978152 |
| 68 | MP0000750_abnormal_muscle_regeneration | 1.14011326 |
| 69 | MP0002136_abnormal_kidney_physiology | 1.13694603 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.12534206 |
| 71 | MP0001542_abnormal_bone_strength | 1.11843466 |
| 72 | MP0000749_muscle_degeneration | 1.11193274 |
| 73 | MP0003011_delayed_dark_adaptation | 1.11085596 |
| 74 | MP0003942_abnormal_urinary_system | 1.10443769 |
| 75 | MP0000762_abnormal_tongue_morphology | 1.10331349 |
| 76 | MP0001984_abnormal_olfaction | 1.10158618 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.09880930 |
| 78 | MP0004043_abnormal_pH_regulation | 1.07478540 |
| 79 | MP0000751_myopathy | 1.05706401 |
| 80 | MP0002160_abnormal_reproductive_system | 1.04971995 |
| 81 | MP0006054_spinal_hemorrhage | 1.04343692 |
| 82 | MP0001529_abnormal_vocalization | 1.03059443 |
| 83 | MP0002876_abnormal_thyroid_physiology | 1.02398137 |
| 84 | MP0009763_increased_sensitivity_to | 1.01318835 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.99805907 |
| 86 | MP0008004_abnormal_stomach_pH | 0.97748925 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.97123779 |
| 88 | MP0005647_abnormal_sex_gland | 0.96862049 |
| 89 | MP0003123_paternal_imprinting | 0.95843807 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.95592384 |
| 91 | MP0002060_abnormal_skin_morphology | 0.94033277 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.92914526 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.92197660 |
| 94 | MP0002163_abnormal_gland_morphology | 0.90371992 |
| 95 | MP0001835_abnormal_antigen_presentation | 0.90359530 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 0.90127599 |
| 97 | MP0002254_reproductive_system_inflammat | 0.89835227 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.89235009 |
| 99 | MP0008058_abnormal_DNA_repair | 0.86484181 |
| 100 | MP0000685_abnormal_immune_system | 0.86477752 |
| 101 | MP0003436_decreased_susceptibility_to | 0.85333894 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.84072693 |
| 103 | MP0002736_abnormal_nociception_after | 0.83730754 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.82855681 |
| 105 | MP0005023_abnormal_wound_healing | 0.82770518 |
| 106 | MP0003724_increased_susceptibility_to | 0.82745002 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.82641683 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.81249485 |
| 109 | MP0002233_abnormal_nose_morphology | 0.78841447 |
| 110 | MP0000163_abnormal_cartilage_morphology | 0.78070486 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.77826422 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.77677939 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.77599697 |
| 114 | MP0004510_myositis | 0.76574734 |
| 115 | MP0000462_abnormal_digestive_system | 0.76316925 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.76020352 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.75344044 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.74611193 |
| 119 | MP0001853_heart_inflammation | 0.74118261 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.73995960 |
| 121 | MP0005408_hypopigmentation | 0.73690392 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.73377670 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.72784154 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71512773 |
| 125 | MP0000604_amyloidosis | 0.70878007 |
| 126 | MP0002928_abnormal_bile_duct | 0.70840178 |
| 127 | MP0009785_altered_susceptibility_to | 0.70588656 |
| 128 | MP0002210_abnormal_sex_determination | 0.69578259 |
| 129 | MP0003937_abnormal_limbs/digits/tail_de | 0.69039637 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.68941380 |
| 131 | MP0001905_abnormal_dopamine_level | 0.68889583 |
| 132 | MP0000358_abnormal_cell_content/ | 0.68659493 |
| 133 | MP0003755_abnormal_palate_morphology | 0.68492116 |
| 134 | MP0005535_abnormal_body_temperature | 0.68220160 |
| 135 | MP0002697_abnormal_eye_size | 0.67105153 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.66735745 |
| 137 | MP0008932_abnormal_embryonic_tissue | 0.66117156 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.65288747 |
| 139 | MP0000613_abnormal_salivary_gland | 0.65262430 |
| 140 | MP0005025_abnormal_response_to | 0.65172940 |
| 141 | MP0005334_abnormal_fat_pad | 0.64336643 |
| 142 | MP0000639_abnormal_adrenal_gland | 0.64175330 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.64141265 |
| 144 | MP0000003_abnormal_adipose_tissue | 0.64122348 |
| 145 | MP0002177_abnormal_outer_ear | 0.63851141 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.63772347 |
| 147 | MP0002971_abnormal_brown_adipose | 0.63360166 |
| 148 | MP0001293_anophthalmia | 0.62239701 |
| 149 | MP0001340_abnormal_eyelid_morphology | 0.62114043 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.61891902 |
| 151 | MP0005266_abnormal_metabolism | 0.61714871 |
| 152 | MP0003300_gastrointestinal_ulcer | 0.61492863 |
| 153 | MP0001958_emphysema | 0.61444243 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.61063988 |
| 155 | MP0004130_abnormal_muscle_cell | 0.58550780 |
| 156 | MP0001800_abnormal_humoral_immune | 0.57806678 |
| 157 | MP0001661_extended_life_span | 0.56811433 |
| 158 | MP0010155_abnormal_intestine_physiology | 0.55242632 |
| 159 | MP0004147_increased_porphyrin_level | 0.54731806 |
| 160 | MP0008873_increased_physiological_sensi | 0.54428933 |
| 161 | MP0002135_abnormal_kidney_morphology | 0.53286296 |
| 162 | MP0005387_immune_system_phenotype | 0.52045968 |
| 163 | MP0001790_abnormal_immune_system | 0.52045968 |
| 164 | MP0003705_abnormal_hypodermis_morpholog | 0.51460975 |
| 165 | MP0004264_abnormal_extraembryonic_tissu | 0.49050830 |
| 166 | MP0000689_abnormal_spleen_morphology | 0.48422456 |
| 167 | MP0002166_altered_tumor_susceptibility | 0.47922821 |
| 168 | MP0001873_stomach_inflammation | 0.46395432 |
| 169 | MP0002419_abnormal_innate_immunity | 0.46280907 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.45146083 |
| 171 | MP0009115_abnormal_fat_cell | 0.44607625 |
| 172 | MP0006082_CNS_inflammation | 0.44603465 |
| 173 | MP0008872_abnormal_physiological_respon | 0.44305483 |
| 174 | MP0003953_abnormal_hormone_level | 0.43847428 |
| 175 | MP0005395_other_phenotype | 0.43326263 |
| 176 | MP0002723_abnormal_immune_serum | 0.41310114 |
| 177 | MP0002970_abnormal_white_adipose | 0.40201803 |
| 178 | MP0000538_abnormal_urinary_bladder | 0.39625887 |
| 179 | MP0005448_abnormal_energy_balance | 0.39394223 |
| 180 | MP0000249_abnormal_blood_vessel | 0.39343034 |
| 181 | MP0005166_decreased_susceptibility_to | 0.37788950 |
| 182 | MP0004947_skin_inflammation | 0.37126510 |
| 183 | MP0008874_decreased_physiological_sensi | 0.36150592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.55819001 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.65018585 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.62122577 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.47703219 |
| 5 | Xanthomatosis (HP:0000991) | 5.05822669 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.84091342 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.72906623 |
| 8 | Hyperglycinuria (HP:0003108) | 4.57544530 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.50204951 |
| 10 | Hyperammonemia (HP:0001987) | 4.47513375 |
| 11 | Ketosis (HP:0001946) | 4.27397766 |
| 12 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19092799 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.17637020 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.16423546 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.16423546 |
| 16 | Hyperglycinemia (HP:0002154) | 4.05618701 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.00777063 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.91663843 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.84874067 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.83816962 |
| 21 | Joint hemorrhage (HP:0005261) | 3.80316801 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.73006315 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.71157728 |
| 24 | Complement deficiency (HP:0004431) | 3.65535140 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.63471903 |
| 26 | Premature rupture of membranes (HP:0001788) | 3.63462391 |
| 27 | Gout (HP:0001997) | 3.63265355 |
| 28 | Hepatocellular necrosis (HP:0001404) | 3.55304575 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.54593842 |
| 30 | Acute encephalopathy (HP:0006846) | 3.54500773 |
| 31 | Mitochondrial inheritance (HP:0001427) | 3.48753183 |
| 32 | Abnormality of nucleobase metabolism (HP:0010932) | 3.46706963 |
| 33 | Progressive macrocephaly (HP:0004481) | 3.45154248 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.45020140 |
| 35 | Fat malabsorption (HP:0002630) | 3.42643362 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.38324493 |
| 37 | Generalized aminoaciduria (HP:0002909) | 3.37917939 |
| 38 | Ketoacidosis (HP:0001993) | 3.37147349 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36018830 |
| 40 | Congenital, generalized hypertrichosis (HP:0004540) | 3.34759376 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.24922612 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.22287540 |
| 43 | Bifid tongue (HP:0010297) | 3.21653714 |
| 44 | Epidermoid cyst (HP:0200040) | 3.20804837 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.17131706 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 3.12734924 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.12734924 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 3.04925289 |
| 49 | Proximal tubulopathy (HP:0000114) | 3.04281536 |
| 50 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.01773644 |
| 51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.01773644 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.97486795 |
| 53 | Metabolic acidosis (HP:0001942) | 2.96225843 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95692560 |
| 55 | Increased CSF lactate (HP:0002490) | 2.95454617 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.94296071 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.87265003 |
| 58 | Lethargy (HP:0001254) | 2.86818074 |
| 59 | Vascular calcification (HP:0004934) | 2.76786188 |
| 60 | Median cleft lip (HP:0000161) | 2.73121470 |
| 61 | Alkalosis (HP:0001948) | 2.72788539 |
| 62 | Steatorrhea (HP:0002570) | 2.69439632 |
| 63 | Delayed gross motor development (HP:0002194) | 2.67495432 |
| 64 | Hyperuricemia (HP:0002149) | 2.65643416 |
| 65 | Increased purine levels (HP:0004368) | 2.65643416 |
| 66 | Abnormality of complement system (HP:0005339) | 2.65179954 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.61989808 |
| 68 | Glycosuria (HP:0003076) | 2.61989808 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.54524191 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.53366489 |
| 71 | Type I transferrin isoform profile (HP:0003642) | 2.51049235 |
| 72 | Cerebral edema (HP:0002181) | 2.47679187 |
| 73 | Nuclear cataract (HP:0100018) | 2.46232192 |
| 74 | Late onset (HP:0003584) | 2.43940534 |
| 75 | Malnutrition (HP:0004395) | 2.42805675 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.40500566 |
| 77 | Vomiting (HP:0002013) | 2.38497274 |
| 78 | Hypoplastic left heart (HP:0004383) | 2.34344689 |
| 79 | Irritability (HP:0000737) | 2.33802962 |
| 80 | Glucose intolerance (HP:0000833) | 2.31027078 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.30852593 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.30852593 |
| 83 | Nausea (HP:0002018) | 2.30726682 |
| 84 | Spastic diplegia (HP:0001264) | 2.30425525 |
| 85 | Pancreatitis (HP:0001733) | 2.30204537 |
| 86 | Methylmalonic acidemia (HP:0002912) | 2.25665290 |
| 87 | Hypokinesia (HP:0002375) | 2.24768649 |
| 88 | Respiratory failure (HP:0002878) | 2.24092442 |
| 89 | Follicular hyperkeratosis (HP:0007502) | 2.23713476 |
| 90 | Exercise intolerance (HP:0003546) | 2.23558373 |
| 91 | Spontaneous abortion (HP:0005268) | 2.23482388 |
| 92 | Myocardial infarction (HP:0001658) | 2.19481130 |
| 93 | Lactic acidosis (HP:0003128) | 2.18114618 |
| 94 | Methylmalonic aciduria (HP:0012120) | 2.16986279 |
| 95 | Neonatal onset (HP:0003623) | 2.16696702 |
| 96 | Abnormal protein glycosylation (HP:0012346) | 2.15773937 |
| 97 | Abnormal glycosylation (HP:0012345) | 2.15773937 |
| 98 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15773937 |
| 99 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15773937 |
| 100 | Anophthalmia (HP:0000528) | 2.10421137 |
| 101 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.09347486 |
| 102 | Selective tooth agenesis (HP:0001592) | 2.06692005 |
| 103 | Increased serum pyruvate (HP:0003542) | 2.05062248 |
| 104 | Brushfield spots (HP:0001088) | 2.04959134 |
| 105 | Esophageal varix (HP:0002040) | 2.04766328 |
| 106 | Gingival bleeding (HP:0000225) | 2.03178642 |
| 107 | Menorrhagia (HP:0000132) | 2.02865459 |
| 108 | Sparse eyelashes (HP:0000653) | 2.02762889 |
| 109 | Rickets (HP:0002748) | 2.01756100 |
| 110 | Renal cortical cysts (HP:0000803) | 2.01564896 |
| 111 | Abnormality of glycolysis (HP:0004366) | 2.01306173 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01106352 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 1.99774074 |
| 114 | Thrombophlebitis (HP:0004418) | 1.98760155 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98507396 |
| 116 | Abnormality of dentin (HP:0010299) | 1.98334403 |
| 117 | Hypoglycemic seizures (HP:0002173) | 1.97576415 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.96964881 |
| 119 | Enlarged kidneys (HP:0000105) | 1.96875918 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.96603040 |
| 121 | Redundant skin (HP:0001582) | 1.96400703 |
| 122 | Sensorimotor neuropathy (HP:0007141) | 1.95509244 |
| 123 | Facial cleft (HP:0002006) | 1.94933377 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.94613396 |
| 125 | Renal Fanconi syndrome (HP:0001994) | 1.94380238 |
| 126 | Entropion (HP:0000621) | 1.93159470 |
| 127 | Glomerulonephritis (HP:0000099) | 1.93007968 |
| 128 | Opisthotonus (HP:0002179) | 1.92957903 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92544259 |
| 130 | Ankle contracture (HP:0006466) | 1.92361570 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.91733912 |
| 132 | Nephrolithiasis (HP:0000787) | 1.91463779 |
| 133 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90314392 |
| 134 | Increased serum lactate (HP:0002151) | 1.90016879 |
| 135 | Increased hepatocellular lipid droplets (HP:0006565) | 1.89965534 |
| 136 | Mitral stenosis (HP:0001718) | 1.89317068 |
| 137 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87591217 |
| 138 | Short nail (HP:0001799) | 1.87482910 |
| 139 | Cutaneous melanoma (HP:0012056) | 1.87305034 |
| 140 | Cholelithiasis (HP:0001081) | 1.86701981 |
| 141 | Adrenal hypoplasia (HP:0000835) | 1.86418450 |
| 142 | Hyperphosphaturia (HP:0003109) | 1.85919733 |
| 143 | Limb-girdle muscle atrophy (HP:0003797) | 1.85035028 |
| 144 | Acanthocytosis (HP:0001927) | 1.84735330 |
| 145 | Abnormal gallbladder morphology (HP:0012437) | 1.84542139 |
| 146 | Hypoplastic heart (HP:0001961) | 1.84380361 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.84340044 |
| 148 | Hyperactive renin-angiotensin system (HP:0000841) | 1.84329661 |
| 149 | Abnormality of placental membranes (HP:0011409) | 1.84032856 |
| 150 | Amniotic constriction ring (HP:0009775) | 1.84032856 |
| 151 | Hypokalemic alkalosis (HP:0001949) | 1.83406295 |
| 152 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83287543 |
| 153 | Abnormal lung lobation (HP:0002101) | 1.82954632 |
| 154 | Hepatic necrosis (HP:0002605) | 1.82768675 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.81589539 |
| 156 | Shoulder girdle muscle weakness (HP:0003547) | 1.80726543 |
| 157 | Skin nodule (HP:0200036) | 1.80439420 |
| 158 | True hermaphroditism (HP:0010459) | 1.80418315 |
| 159 | CNS demyelination (HP:0007305) | 1.79210414 |
| 160 | Soft skin (HP:0000977) | 1.78842969 |
| 161 | Patent foramen ovale (HP:0001655) | 1.77807692 |
| 162 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.77466875 |
| 163 | Megaloblastic anemia (HP:0001889) | 1.75840671 |
| 164 | Trismus (HP:0000211) | 1.75613262 |
| 165 | Vacuolated lymphocytes (HP:0001922) | 1.73873003 |
| 166 | Molar tooth sign on MRI (HP:0002419) | 1.70050013 |
| 167 | Abnormality of midbrain morphology (HP:0002418) | 1.70050013 |
| 168 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.68620418 |
| 169 | Gonadal dysgenesis (HP:0000133) | 1.67958080 |
| 170 | Meningioma (HP:0002858) | 1.63719262 |
| 171 | Sclerocornea (HP:0000647) | 1.63478949 |
| 172 | Cholecystitis (HP:0001082) | 1.61116213 |
| 173 | Abnormal gallbladder physiology (HP:0012438) | 1.61116213 |
| 174 | Conjunctival hamartoma (HP:0100780) | 1.60352305 |
| 175 | Large for gestational age (HP:0001520) | 1.60335893 |
| 176 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60326656 |
| 177 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.59718006 |
| 178 | Optic disc pallor (HP:0000543) | 1.56978993 |
| 179 | Hypoplasia of the uterus (HP:0000013) | 1.56847577 |
| 180 | Pancreatic fibrosis (HP:0100732) | 1.54708216 |
| 181 | Hamartoma of the eye (HP:0010568) | 1.54260069 |
| 182 | Rough bone trabeculation (HP:0100670) | 1.54064897 |
| 183 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.50174753 |
| 184 | Down-sloping shoulders (HP:0200021) | 1.48445644 |
| 185 | Microglossia (HP:0000171) | 1.48343125 |
| 186 | Exercise-induced muscle cramps (HP:0003710) | 1.47251720 |
| 187 | Recurrent corneal erosions (HP:0000495) | 1.47168373 |
| 188 | Abnormality of renal resorption (HP:0011038) | 1.46665927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.99034705 |
| 2 | PBK | 4.03492716 |
| 3 | MAP3K12 | 3.98225437 |
| 4 | BUB1 | 3.90009099 |
| 5 | ERN1 | 3.73837775 |
| 6 | FGFR4 | 3.25186382 |
| 7 | VRK2 | 3.25004565 |
| 8 | MST4 | 2.93718161 |
| 9 | MAP4K1 | 2.69667465 |
| 10 | TAOK3 | 2.67234052 |
| 11 | SIK1 | 2.59124574 |
| 12 | TAF1 | 2.54784445 |
| 13 | EPHA2 | 2.27752119 |
| 14 | FLT3 | 2.26194744 |
| 15 | TRIM28 | 2.24984299 |
| 16 | NME2 | 2.24195270 |
| 17 | NME1 | 2.13779789 |
| 18 | WNK4 | 2.11286326 |
| 19 | TYK2 | 2.05297414 |
| 20 | TNIK | 2.05136680 |
| 21 | TGFBR2 | 2.05011084 |
| 22 | WNK3 | 1.99370302 |
| 23 | PKN2 | 1.99360408 |
| 24 | KDR | 1.88265169 |
| 25 | MAP3K9 | 1.80325503 |
| 26 | WEE1 | 1.75017691 |
| 27 | GRK6 | 1.68536487 |
| 28 | TBK1 | 1.65284178 |
| 29 | MST1R | 1.61606865 |
| 30 | ARAF | 1.59712854 |
| 31 | LMTK2 | 1.55415196 |
| 32 | MAP2K3 | 1.53785783 |
| 33 | LIMK1 | 1.53137149 |
| 34 | MAPK11 | 1.47218582 |
| 35 | TIE1 | 1.44570945 |
| 36 | TRIB3 | 1.43588990 |
| 37 | PNCK | 1.42700408 |
| 38 | PTK2 | 1.40597866 |
| 39 | VRK1 | 1.37213710 |
| 40 | PAK4 | 1.36571336 |
| 41 | TESK1 | 1.35105164 |
| 42 | CSF1R | 1.34488909 |
| 43 | IRAK3 | 1.31356039 |
| 44 | PIK3CG | 1.30618050 |
| 45 | TGFBR1 | 1.30027762 |
| 46 | MAP3K14 | 1.28862337 |
| 47 | MAP3K10 | 1.28060108 |
| 48 | ZAP70 | 1.25102750 |
| 49 | IKBKE | 1.22789717 |
| 50 | INSRR | 1.20889090 |
| 51 | BTK | 1.20232564 |
| 52 | EIF2AK1 | 1.20127277 |
| 53 | LATS2 | 1.17386124 |
| 54 | OXSR1 | 1.14846956 |
| 55 | CDC7 | 1.13488943 |
| 56 | KIT | 1.10338943 |
| 57 | PLK3 | 1.10200114 |
| 58 | PTK6 | 1.09776755 |
| 59 | BLK | 1.04825162 |
| 60 | TEC | 1.04180305 |
| 61 | JAK2 | 1.02564522 |
| 62 | LRRK2 | 1.02135904 |
| 63 | ABL2 | 1.01604222 |
| 64 | NEK9 | 0.98238444 |
| 65 | MAP3K11 | 0.98214144 |
| 66 | PDK3 | 0.95995743 |
| 67 | PDK4 | 0.95995743 |
| 68 | ILK | 0.95049290 |
| 69 | MAP2K6 | 0.94435387 |
| 70 | EPHB2 | 0.93303107 |
| 71 | NTRK3 | 0.91996874 |
| 72 | DAPK1 | 0.91810723 |
| 73 | JAK3 | 0.90329967 |
| 74 | MAP3K3 | 0.89664798 |
| 75 | BRSK1 | 0.89124487 |
| 76 | CSNK1G3 | 0.88716113 |
| 77 | EEF2K | 0.87806949 |
| 78 | CSNK1G1 | 0.86781159 |
| 79 | EIF2AK2 | 0.84766428 |
| 80 | PINK1 | 0.83732641 |
| 81 | FGFR2 | 0.82638481 |
| 82 | PHKG2 | 0.82290036 |
| 83 | PHKG1 | 0.82290036 |
| 84 | SYK | 0.81735108 |
| 85 | ERBB4 | 0.80888132 |
| 86 | BMPR1B | 0.77895312 |
| 87 | MOS | 0.77662830 |
| 88 | MAP3K7 | 0.77329066 |
| 89 | DDR2 | 0.76774111 |
| 90 | MAPK4 | 0.75237543 |
| 91 | DYRK2 | 0.74808771 |
| 92 | STK38L | 0.74796701 |
| 93 | PRKAA2 | 0.74699121 |
| 94 | PLK4 | 0.74234493 |
| 95 | NUAK1 | 0.73267522 |
| 96 | JAK1 | 0.73100845 |
| 97 | CSNK1G2 | 0.70508056 |
| 98 | ITK | 0.70474130 |
| 99 | MAP2K2 | 0.70307971 |
| 100 | CAMK2D | 0.70266705 |
| 101 | DYRK1B | 0.70187772 |
| 102 | PIM1 | 0.68797092 |
| 103 | IKBKB | 0.68608647 |
| 104 | FGFR1 | 0.68326093 |
| 105 | PTK2B | 0.66558951 |
| 106 | PDGFRA | 0.66067651 |
| 107 | FRK | 0.65935767 |
| 108 | CDK4 | 0.63925405 |
| 109 | CDK6 | 0.63505922 |
| 110 | ADRBK1 | 0.63100298 |
| 111 | CSK | 0.63084186 |
| 112 | TXK | 0.62652585 |
| 113 | STK38 | 0.62566029 |
| 114 | DMPK | 0.61358973 |
| 115 | CSNK1A1L | 0.61090598 |
| 116 | STK16 | 0.60396201 |
| 117 | LYN | 0.60164018 |
| 118 | STK10 | 0.59664799 |
| 119 | ACVR1B | 0.59571408 |
| 120 | PLK1 | 0.59284002 |
| 121 | DAPK3 | 0.59260479 |
| 122 | TSSK6 | 0.57278751 |
| 123 | NTRK1 | 0.57258660 |
| 124 | MYLK | 0.56783709 |
| 125 | RPS6KA4 | 0.54929647 |
| 126 | PRKD3 | 0.54654041 |
| 127 | CAMK2G | 0.54068452 |
| 128 | NLK | 0.49136331 |
| 129 | TAOK2 | 0.48714700 |
| 130 | PRKCE | 0.48581447 |
| 131 | MAPKAPK3 | 0.48565799 |
| 132 | PRKG2 | 0.48504230 |
| 133 | DAPK2 | 0.48178159 |
| 134 | TTK | 0.47032399 |
| 135 | CSNK2A2 | 0.45778049 |
| 136 | MAPK12 | 0.45383449 |
| 137 | MAPK15 | 0.45155514 |
| 138 | MET | 0.44509554 |
| 139 | MKNK2 | 0.43296904 |
| 140 | AURKA | 0.43183552 |
| 141 | PDK2 | 0.41898493 |
| 142 | CAMK2B | 0.41878706 |
| 143 | PAK1 | 0.41855735 |
| 144 | PIM2 | 0.41725881 |
| 145 | EPHB1 | 0.41655912 |
| 146 | PRKCQ | 0.41465958 |
| 147 | PDK1 | 0.41171661 |
| 148 | CDK7 | 0.40950026 |
| 149 | CHUK | 0.40582823 |
| 150 | CHEK2 | 0.40340690 |
| 151 | PRKACG | 0.39583434 |
| 152 | MAP2K4 | 0.39562548 |
| 153 | EIF2AK3 | 0.39561871 |
| 154 | STK39 | 0.39397023 |
| 155 | AURKB | 0.38695944 |
| 156 | PAK2 | 0.38344204 |
| 157 | GSK3A | 0.37334014 |
| 158 | MAP3K8 | 0.37186399 |
| 159 | NEK1 | 0.37100243 |
| 160 | DYRK3 | 0.36618311 |
| 161 | SGK3 | 0.35024872 |
| 162 | GRK5 | 0.34979948 |
| 163 | ROCK1 | 0.33527564 |
| 164 | ADRBK2 | 0.33428963 |
| 165 | CSNK2A1 | 0.32995355 |
| 166 | PRKAA1 | 0.32011880 |
| 167 | LCK | 0.31563548 |
| 168 | PRKCZ | 0.31529655 |
| 169 | RPS6KB2 | 0.31520522 |
| 170 | GRK1 | 0.31016916 |
| 171 | STK4 | 0.27549984 |
| 172 | IGF1R | 0.27491397 |
| 173 | PRKCD | 0.26968326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.19143203 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.81628339 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54481867 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.36916084 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87973063 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.84282604 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73590034 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.68626593 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67760745 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66009763 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.61487418 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.60006655 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58882781 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50177643 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41532732 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28887621 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.23500027 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19492236 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 2.14146859 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11039844 |
| 21 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05642917 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 2.02485083 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.98497658 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95203502 |
| 25 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87939303 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.86375922 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84150771 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83028121 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83018972 |
| 30 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82346237 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81955788 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80771470 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76572241 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76026326 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74323088 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73404183 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70901140 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.67889855 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65586787 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64825059 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64740204 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55175611 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52854056 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.51435496 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50083377 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45967816 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44030902 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43818875 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40330977 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.39387582 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39049995 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36988664 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36525268 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32115074 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29851056 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29318733 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28964146 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27445749 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22176020 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21326812 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 1.18319211 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17891324 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14051355 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13787746 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12266535 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11449758 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09114531 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.09017879 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08121101 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06097766 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01500566 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00821893 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99514649 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97570073 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96213572 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95810139 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94194646 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92200495 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91415451 |
| 80 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.91357750 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87100272 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.84344895 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84173920 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83285520 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82025069 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.81650486 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78572711 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78466416 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72620875 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69920614 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67147139 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60320908 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58343381 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58282753 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56746793 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56543259 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55460932 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.54206482 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54126800 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48818166 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48323425 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.47739650 |
| 103 | Spliceosome_Homo sapiens_hsa03040 | 0.44207307 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40843199 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37169609 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.36061203 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33807358 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32776680 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31252376 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31232249 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31068075 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21977907 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21635756 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19862461 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18766818 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16721248 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.16332094 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15698748 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.12472752 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.11135200 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09744259 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.09439058 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07538944 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04422994 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.01063309 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.1299671 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.1297370 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | -0.1265073 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1253205 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1226983 |
| 131 | Lysosome_Homo sapiens_hsa04142 | -0.1222209 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1160927 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | -0.1055805 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | -0.1030796 |
| 135 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0906960 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0696376 |
| 137 | Protein export_Homo sapiens_hsa03060 | -0.0681924 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0536431 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0202814 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0077364 |

